EURObservational Research Programme - ELECTRa Registry The implant rate of Cardiovascular Implantable Electronic Devices (CIED) continues to rise in most countries. The number of leads per patient is increasing due to a higher proportion of dual versus single chamber devices and an increase of CRTP/D systems. Greater life expectancy, need for upgrade, multiple replacements of generators or pocket revisions for complications expose patients to infections.
Despite advances in technology and improvements in reliability, leads remain the weak point of the systems and in some cases may fail.
Transvenous Lead Extraction is the gold standard in the treatment of CIED related infective complications and often required in the management of leads malfunction.
Initially NASPE and subsequently HRS and European Heart Rhythm Association (EHRA) have published recommendations describing indications, settings, facilities, training and accreditation for transvenous lead extraction procedures.
ELECTRa is made possible thanks to an unrestricted grant from Spectranetics, Zoll and Cook Medical.
It is anticipated that over 100 centres will participate in the registry.Each centre will register consecutive patients for a total of 3500 patients. The study should commence recruitment of patients in November 2012 and finish in June 2013. Centres will be enrolled on a voluntary basis from all the European Countries and will be anonymous and stratified on the basis of their volume of activity.
Read the article published in the Europace JournalDownload the eCRF and the Protocol.
Maria Grazia Bongiorni, chair - ItalyCharles Kennergren, co-chair - SwedenChristian Butter - Germany Jean Claude Deharo - FranceAndrzej Kutarski - PolandAldo Rinaldi - United KingdomAldo Maggioni , EORP - ItalyCarina Blomstrom-Lundqvist - SwedenAngelo Auricchio - Switzerland
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved